Effects of hypothalamic lesions and drugs interfering with dopaminergic transmission on pituitary MSH content of rats
- PMID: 206853
- DOI: 10.1159/000122748
Effects of hypothalamic lesions and drugs interfering with dopaminergic transmission on pituitary MSH content of rats
Abstract
The physiological significance of the dopaminergic innervation of the pars intermedia was studied in rats. Electrothermic lesions were made in the mediobasal hypothalamus in order to destroy all hypothalamo-hypophysial connections. Pituitary MSH content decreased to 25% of control values 8 h after lesioning. From the 1st day, however, pituitary MSH content gradually increased, reaching control levels after about 1 week. Haloperidol and pimozide (both neuroleptics) were used to block specifically dopamine (DA)-receptors. Single administration of these drugs induced a time and dose dependent reduction in pituitary MSH. A maximal decrease to about 60% was found 4-5 h after i.p. administration of 2.5 mg/kg haloperidol and 1.0 mg/kg pimozide. Apomorphine and 2-Br-alpha-ergocryptine (DA-receptor stimulating drugs), had no effect on pituitary MSH stores of intact rats, but completely prevented the lesion-induced fall in pituitary MSH content. The results show that DA-receptors located within the pituitary itself are involved in the control of MSH release indicating that the effect of hypothalamic lesions on pituitary MSH content is primarily caused by interruption of dopaminergic neurotransmission in the hypophysis. We conclude therefore that the dopaminergic arcuato-hypophysial neurones innervating the pars intermedia tonically inhibit the release of MSH in intact rats.
Similar articles
-
An improved radioimmunoassay for alpha-melanocyte-stimulating hormone (alpha-MSH) in the rat: serum and pituitary alpha-MSH levels after drugs which modify catecholaminergic neurotransmission.Neuroendocrinology. 1978;25(4):193-203. doi: 10.1159/000122741. Neuroendocrinology. 1978. PMID: 206851
-
The hypothalamo-hypophyseal rat explant in vitro: endocrinological studies of the pars intermedia dopaminergic neural input.J Physiol. 1986 Jan;370:381-93. doi: 10.1113/jphysiol.1986.sp015940. J Physiol. 1986. PMID: 3958980 Free PMC article.
-
Hypothalamic alpha-melanocyte-stimulating hormone (alpha-MSH) is not under dopaminergic control.Brain Res. 1987 Oct 13;423(1-2):203-12. doi: 10.1016/0006-8993(87)90841-9. Brain Res. 1987. PMID: 2960424
-
Melanocyte-stimulating hormone and persistent tardive dyskinesia: a hypothesis.Int J Neurosci. 1990 Mar;51(1-2):45-52. doi: 10.3109/00207459009000507. Int J Neurosci. 1990. PMID: 1979965 Review.
-
Alpha-melanocyte-stimulating hormone and behavior.Neurosci Biobehav Rev. 1982 Fall;6(3):297-310. doi: 10.1016/0149-7634(82)90042-2. Neurosci Biobehav Rev. 1982. PMID: 6294567 Review.
Cited by
-
Effects of pimozide on the ultrastructure of the pars intermedia in the rat.Cell Tissue Res. 1981;217(2):397-403. doi: 10.1007/BF00233589. Cell Tissue Res. 1981. PMID: 7237535
-
The effect of hypothalamic lesions on immuno-reactive alpha-melanocyte stimulating hormone secretion in the rat.J Physiol. 1979 Jul;292:59-67. doi: 10.1113/jphysiol.1979.sp012838. J Physiol. 1979. PMID: 490393 Free PMC article.
-
A possible role for intermediate lobe peptides in the pathogenesis of idiopathic aldosteronism.Trans Am Clin Climatol Assoc. 1984;95:26-33. Trans Am Clin Climatol Assoc. 1984. PMID: 6089399 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous